“…Each antibiotic regimen has advantages or disadvantages in terms of cost, convenience, and compliance, yet both regimens will remain www.intechopen.com recommended as first-line therapy for uncomplicated chlamydial infection in nonpregnant individuals [140]. However, in patients who have erratic health-care-seeking behavior, poor treatment compliance, or unpredictable follow-up, azithromycin might be more costeffective in treating chlamydia because it enables the provision of a single-dose of directly observed therapy [139,141].…”